Skip to content

Color Doppler and Mri Diffusion in Major Salivary Gland Masses

Combined Role of Color Doppler and Diffusion Weighted MRI In Differentiation Between Benign and Malignant Tumors of Major Salivary Glands

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03893812
Enrollment
50
Registered
2019-03-28
Start date
2019-10-31
Completion date
2019-11-30
Last updated
2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Salivary Gland Diseases

Brief summary

This study intend to evaluate the combined value of ADC and COLOR DOPPLER in differentiating benign and malignant salivary gland tumors in comparison to histopathological findings and its use in preoperative prediction of benign and malignant masses.

Detailed description

the study aim to achieve preoperative differentiation between benign and malignant masses of the major salivary glands using the ADC values and Color Doppler values (PSV - PI - RI)

Interventions

DEVICEMRI

diffusion weighted MR

DEVICEUltrasound

Color Doppler ultrasound

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1- patients must be 18 of age or older. 2= patients must have a suspicious swelling in major salivary glands.

Exclusion criteria

1. Patients with history of metal plates or screws or artificial joints. 2. Patients who have phobia of indoor places. 3. Patients with contraindication to MRI like intra-cerebral aneurysmal clips, cardiac pacemaker, and metallic foreign body at region of examination.

Design outcomes

Primary

MeasureTime frameDescription
The ADC values and Color Doppler values (PSV-PI-RI) of major salivary gland massesbaselineThe ADC values and Color Doppler values (PSV-PI-RI) of major salivary gland masses will differ according to the nature of the mass determined by histopathological finding

Contacts

Primary ContactMohamed AH Alam El-Din, Doctor
mohamedalam03@gmail.com01093900515
Backup ContactRadwa KA Abd El-Naser, MD
radwa.soliman@yahoo.co.ek01009910070

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026